Indivumed is a biotech company focusing on precision oncology. For almost 25 years, we have been driven by a single, overarching vision: a world in which precision therapy offers a cure for every cancer patient.

Specialized in early drug discovery, our R&D approach is based on the belief that we need to fundamentally understand the disease to gain novel insights and develop effective therapeutics. To do so, we start with carefully collected and curated patient samples, resulting in a comprehensive and proprietary database. By employing advanced biomathematical and bioinformatic methods on this excellent data, we discover therapeutically novel targets. From our high-quality tissue, we generate patient-derived 2D and 3D cellular models allowing us to perform target validation and therapeutic development in an environment that is as close to the patient as possible.

Drive, dedication, and our shared purpose make us who we are.

Driven by ...